Development and internal validation of a prediction model for new-onset macular oedema following vitrectomy for diabetic retinopathy: a single-centre retrospective analysis
- 1Department of Ophthalmology, Fuyang People’s Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, China
- 2Department of Ophthalmology, Fuyang Hospital Affiliated to Bengbu Medical University (Fuyang People’s Hospital), Fuyang, Anhui, China
Abstract
Objective: To develop and internally validate a compact model for estimating the 1-year risk of new-onset postoperative macular oedema in patients with diabetic retinopathy undergoing vitrectomy.
Methods: This single-centre retrospective cohort included 650 recorded patients treated from January 2023 to April 2025. The primary analysis comprised 607 patients with ascertainable 1-year outcomes, with one study eye per patient; 43 patients lost to follow-up were assessed separately. New-onset macular oedema required new intraretinal cystoid spaces and/or subretinal fluid on optical coherence tomography during postoperative days 30–365, together with central macular thickness ≥300 μm or an increase ≥30 μm from baseline. The five-predictor logistic model used pre-incision measurements and was fitted in all 607 patients. Internal validation used 1, 000 bootstrap resamples; a 32-candidate, 10-fold cross-validated least absolute shrinkage and selection operator (LASSO) analysis with selection-inclusive bootstrap validation assessed the stability of the separate LASSO procedure.
Results: New-onset postoperative macular oedema occurred in 207 of 607 patients (34.1%). The apparent area under the receiver operating characteristic curve (AUC) was 0.823 and the optimism-corrected AUC was 0.818. The corresponding Brier scores were 0.159 and 0.163; the corrected calibration intercept and slope were −0.011 and 0.969. At an illustrative probability threshold of 0.30, 40 of 323 patients (12.4%) in the lower-risk group and 167 of 284 (58.8%) in the higher-risk group developed the outcome. Selection-inclusive validation of the LASSO sensitivity model yielded a corrected AUC of 0.805. Systolic pressure was not statistically significant in the five-predictor model (P = 0.329).
Conclusion: The five-variable model showed useful discrimination and acceptable bootstrap-corrected calibration in this single-centre cohort. It should be regarded as an internally validated risk-stratification model that requires external and prospective validation before clinical implementation.
Related
- Development and Internal Validation of a Risk Prediction Model for Visual Impairment Progression in Elderly Patients with Diabetic Retinopathy: A Single-Center Retrospective Study.
- Development and internal validation of an exploratory clinical prediction model for MRI-defined white matter injury in moderate-to-late preterm infants: a single-center retrospective study
- Development and Internal Validation of a Preintubation Prediction Model for Postintubation Hypotension in Trauma Patients Undergoing Emergency Endotracheal Intubation: A Retrospective Cohort Study
- Development and validation of a clinical prediction model for diagnosing nephrotic syndrome in adults: a retrospective diagnostic prediction study
- Development and Internal Validation of a Retrospective Prediction Model for Fungal Infections in Patients with Chronic Obstructive Pulmonary Disease.
BibTeX
@article{ma2026development,
title = {{Development and internal validation of a prediction model for new-onset macular oedema following vitrectomy for diabetic retinopathy: a single-centre retrospective analysis}},
author = {Jiayu Ma and Jing Wang and Yiwei Wang and Chenyu Yang and Jiahao Li and Yingjun Li},
journal = {Frontiers in Ophthalmology},
year = {2026},
month = oct,
doi = {10.3389/fopht.2026.1932517},
url = {https://doi.org/10.3389/fopht.2026.1932517},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Development and internal validation of a prediction model for new-onset macular oedema following vitrectomy for diabetic retinopathy: a single-centre retrospective analysis
AU - Jiayu Ma
AU - Jing Wang
AU - Yiwei Wang
AU - Chenyu Yang
AU - Jiahao Li
AU - Yingjun Li
PY - 2026
DA - 2026/10/29
JO - Frontiers in Ophthalmology
DO - 10.3389/fopht.2026.1932517
UR - https://doi.org/10.3389/fopht.2026.1932517
AB - Objective: To develop and internally validate a compact model for estimating the 1-year risk of new-onset postoperative macular oedema in patients with diabetic retinopathy undergoing vitrectomy. Methods: This single-centre retrospective cohort included 650 recorded patients treated from January 2023 to April 2025. The primary analysis comprised 607 patients with ascertainable 1-year outcomes, with one study eye per patient; 43 patients lost to follow-up were assessed separately. New-onset macular oedema required new intraretinal cystoid spaces and/or subretinal fluid on optical coherence tomography during postoperative days 30–365, together with central macular thickness ≥300 μm or an increase ≥30 μm from baseline. The five-predictor logistic model used pre-incision measurements and was fitted in all 607 patients. Internal validation used 1, 000 bootstrap resamples; a 32-candidate, 10-fold cross-validated least absolute shrinkage and selection operator (LASSO) analysis with selection-inclusive bootstrap validation assessed the stability of the separate LASSO procedure. Results: New-onset postoperative macular oedema occurred in 207 of 607 patients (34.1%). The apparent area under the receiver operating characteristic curve (AUC) was 0.823 and the optimism-corrected AUC was 0.818. The corresponding Brier scores were 0.159 and 0.163; the corrected calibration intercept and slope were −0.011 and 0.969. At an illustrative probability threshold of 0.30, 40 of 323 patients (12.4%) in the lower-risk group and 167 of 284 (58.8%) in the higher-risk group developed the outcome. Selection-inclusive validation of the LASSO sensitivity model yielded a corrected AUC of 0.805. Systolic pressure was not statistically significant in the five-predictor model (P = 0.329). Conclusion: The five-variable model showed useful discrimination and acceptable bootstrap-corrected calibration in this single-centre cohort. It should be regarded as an internally validated risk-stratification model that requires external and prospective validation before clinical implementation.
SN - 2674-0826
ER -